Glycoprotein IIb-IIIa inhibitors - do we still need them?
作者信息
Subban Vijayakumar, Sarat Chandra K
机构信息
Section Editor, Indian Heart Journal.
出版信息
Indian Heart J. 2013 May-Jun;65(3):260-3. doi: 10.1016/j.ihj.2013.04.032. Epub 2013 Apr 25.
Abstract
摘要
相似文献
1
Glycoprotein IIb-IIIa inhibitors - do we still need them?糖蛋白IIb-IIIa抑制剂——我们仍然需要它们吗？
Indian Heart J. 2013 May-Jun;65(3):260-3. doi: 10.1016/j.ihj.2013.04.032. Epub 2013 Apr 25.
2
Comparison of heparin, bivalirudin, and different glycoprotein IIb/IIIa inhibitor regimens for anticoagulation during percutaneous coronary intervention: A network meta-analysis.经皮冠状动脉介入治疗期间肝素、比伐卢定及不同糖蛋白IIb/IIIa抑制剂抗凝方案的比较：一项网状Meta分析。
Cardiovasc Revasc Med. 2016 Dec;17(8):535-545. doi: 10.1016/j.carrev.2016.09.011. Epub 2016 Sep 30.
3
Efficacy and safety of bivalirudin in patients receiving clopidogrel therapy after diagnostic angiography for percutaneous coronary intervention in acute coronary syndromes.诊断性冠状动脉造影后接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者中应用比伐卢定的疗效和安全性。
Catheter Cardiovasc Interv. 2010 Oct 1;76(4):513-24. doi: 10.1002/ccd.22546.
4
It is standard practice, but is it really best practice or clinical biocreep?这是标准做法，但它真的是最佳做法还是临床渐变呢？
Catheter Cardiovasc Interv. 2010 Oct 1;76(4):525-6. doi: 10.1002/ccd.22775.
5
Comparison of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitors in patients undergoing an invasive strategy: a meta-analysis of randomized clinical trials.比较接受有创策略的患者中比伐卢定与肝素加糖蛋白 IIb/IIIa 抑制剂的疗效：随机临床试验的荟萃分析。
Int J Cardiol. 2011 Nov 3;152(3):369-74. doi: 10.1016/j.ijcard.2010.08.007. Epub 2010 Sep 16.
6
Why we need intravenous antiplatelet agents.我们为何需要静脉注射抗血小板药物。
Future Cardiol. 2016 Sep;12(5):553-61. doi: 10.2217/fca-2016-0002. Epub 2016 Jun 3.
7
Meta-analysis of randomized clinical trials comparing bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention and in patients with ST-segment elevation myocardial infarction.经皮冠状动脉介入治疗和 ST 段抬高型心肌梗死患者中比伐卢定与肝素加糖蛋白 IIb/IIIa 抑制剂比较的随机临床试验的荟萃分析。
Am J Cardiol. 2014 Jul 15;114(2):250-9. doi: 10.1016/j.amjcard.2014.04.033. Epub 2014 May 2.
8
Evaluation of Ischemic and Bleeding Risks Associated With 2 Parenteral Antiplatelet Strategies Comparing Cangrelor With Glycoprotein IIb/IIIa Inhibitors: An Exploratory Analysis From the CHAMPION Trials.比较坎格瑞洛与糖蛋白 IIb/IIIa 抑制剂的两种静脉用抗血小板策略与缺血和出血风险相关的评估：来自 CHAMPION 试验的探索性分析。
JAMA Cardiol. 2017 Feb 1;2(2):127-135. doi: 10.1001/jamacardio.2016.4556.
9
A randomized two-by-two comparison of high-dose bolus tirofiban versus abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary revascularization and stent placement: the tirofiban evaluation of novel dosing versus abciximab with clopidogrel and inhibition of thrombin (TENACITY) study trial.经皮冠状动脉血运重建和支架置入术中高剂量推注替罗非班与阿昔单抗和普通肝素与比伐卢定的随机两因素两水平比较：替罗非班新型给药方案与氯吡格雷联合阿昔单抗抑制血小板糖蛋白Ⅱb/Ⅲa 受体（TENACITY）研究。
Catheter Cardiovasc Interv. 2011 Jun 1;77(7):1001-9. doi: 10.1002/ccd.22876. Epub 2011 Jan 11.
10
Bivalirudin compared with IIb/IIIa inhibitors in patients with in-stent restenosis undergoing intracoronary brachytherapy.在接受冠状动脉内近距离放射治疗的支架内再狭窄患者中，比伐卢定与IIb/IIIa抑制剂的比较。
Cardiovasc Revasc Med. 2005 Oct-Dec;6(4):154-9. doi: 10.1016/j.carrev.2005.06.003.
引用本文的文献
1
Antiplatelet Therapy in Acute Coronary Syndrome.急性冠状动脉综合征中的抗血小板治疗
Eur Cardiol. 2017 Aug;12(1):33-37. doi: 10.15420/ecr.2016:34:2.
2
Regulation of platelet function and thrombosis by omega-3 and omega-6 polyunsaturated fatty acids.ω-3和ω-6多不饱和脂肪酸对血小板功能和血栓形成的调节作用
Prostaglandins Other Lipid Mediat. 2018 Nov;139:10-18. doi: 10.1016/j.prostaglandins.2018.09.005. Epub 2018 Sep 25.
本文引用的文献
1
Intracoronary abciximab in STEMI using local drug delivery catheter - single center experience.使用局部给药导管在ST段抬高型心肌梗死中应用冠状动脉内阿昔单抗——单中心经验
Indian Heart J. 2013 May-Jun;65(3):256-9. doi: 10.1016/j.ihj.2013.04.021. Epub 2013 Apr 12.
2
Effect of platelet inhibition with cangrelor during PCI on ischemic events.PCI 中用坎格瑞洛进行血小板抑制对缺血事件的影响。
N Engl J Med. 2013 Apr 4;368(14):1303-13. doi: 10.1056/NEJMoa1300815. Epub 2013 Mar 10.
3
Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA STEMI trial.急性 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗时冠状动脉内与静脉内推注阿昔单抗的比较：AIDA STEMI 试验的心脏磁共振子研究。
J Am Coll Cardiol. 2013 Apr 2;61(13):1447-54. doi: 10.1016/j.jacc.2013.01.048. Epub 2013 Feb 27.
4
Intracoronary glycoprotein IIb/IIIa inhibitor infusion via a perfusion coronary catheter to decrease thrombus burden: results from the ClearWay™ Multicenter Registry.经灌注冠状动脉导管输注冠状动脉内糖蛋白IIb/IIIa抑制剂以减轻血栓负荷：ClearWay™多中心注册研究结果
Cardiovasc Revasc Med. 2013 Sep-Oct;14(5):280-3. doi: 10.1016/j.carrev.2012.12.006. Epub 2013 Jan 30.
5
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2013年美国心脏病学会基金会/美国心脏协会ST段抬高型心肌梗死管理指南：美国心脏病学会基金会/美国心脏协会实践指南工作组报告
J Am Coll Cardiol. 2013 Jan 29;61(4):e78-e140. doi: 10.1016/j.jacc.2012.11.019. Epub 2012 Dec 17.
6
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.ST段抬高型急性心肌梗死患者管理的欧洲心脏病学会指南
Eur Heart J. 2012 Oct;33(20):2569-619. doi: 10.1093/eurheartj/ehs215. Epub 2012 Aug 24.
7
2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2012年美国心脏病学会基金会/美国心脏协会实践指南工作组关于不稳定型心绞痛/非ST段抬高型心肌梗死患者管理指南的重点更新（更新2007年指南并取代2011年重点更新）
J Am Coll Cardiol. 2012 Aug 14;60(7):645-81. doi: 10.1016/j.jacc.2012.06.004. Epub 2012 Jul 16.
8
Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial.冠状动脉内阿昔单抗和血栓抽吸术治疗大面积前壁心肌梗死患者：INFUSE-AMI 随机试验。
JAMA. 2012 May 2;307(17):1817-26. doi: 10.1001/jama.2012.421. Epub 2012 Mar 25.
9
Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial.急性 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗时冠状动脉内与静脉内推注阿昔单抗的随机试验。
Lancet. 2012 Mar 10;379(9819):923-931. doi: 10.1016/S0140-6736(11)61872-2. Epub 2012 Feb 21.
10
Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction.阿昔单抗和肝素与比伐卢定用于非 ST 段抬高型心肌梗死。
N Engl J Med. 2011 Nov 24;365(21):1980-9. doi: 10.1056/NEJMoa1109596. Epub 2011 Nov 13.
Zotero 插件